Two new restaurants coming soon to Burnsville Center
Two new restaurants coming soon to Burnsville Center originally appeared on Bring Me The News.
Two new restaurants are coming soon to Burnsville Center, bringing flavors from South Korea and Japan to the former Applebee's space.
Chingu Korean Fried Chicken promises Korean street food classics and, of course, chicken wings.
No opening date has been announced, but the restaurant is teasing a grand opening announcement on social media.
"From saucy wings to loaded fries and all the bold Korean flavors you crave — your new favorite chicken spot is almost here," the restaurant shared.
Kyo Matcha, which has roughly a dozen U.S. locations, is also in the works.
The Burnsville cafe will be Kyo Matcha's second in the Twin Cities, joining Minnesota's first location that opened in Richfield last year.
The matcha cafe focuses on drinks and desserts featuring high-quality matcha.
"Due to the influence of the Japanese-style matcha culture, the Kyoto Matcha is based on the brand mission of 'Let the Tea Return to the Forest', rooted in the traditional Japanese tea culture and dedicated to the promotion of Matcha culture," the cafe's website shares.
The menu includes a wide range of photo-worthy treats.
There's a brown sugar boba milk cake, a peach oolong crepe layer cake and many others - including whipped cream-stuffed cakes delicately rolled to look like a towel.
One of the destination's signature treats is the matcha ice cream parfait, which features cornflakes, red beans and rice mochi.
Over on the mall's northern extension, the wait continues for the long-delayed Asian supermarket and food hall transforming the former Gordman's space.
No opening date has been announced.
This story was originally reported by Bring Me The News on Jun 9, 2025, where it first appeared.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
2 hours ago
- CNBC
Dollar advances as investors brace for Iran response to U.S. attacks
The U.S. dollar firmed on Monday as anxious investors sought safety, although the restrained moves suggest markets were waiting for Iran's response to U.S. attacks on its nuclear sites that have exacerbated conflict in the Middle East. The major moves were in the oil market, with crude prices hitting a five-month high, while global stocks slipped after the U.S. attacked Iran's nuclear sites and President Donald Trump raised the idea of regime change in the Islamic republic. In currency markets, the euro was 0.5% lower at $1.1469, while the Australian dollar, often seen as risk proxy, was last 1.1% weaker at $0.6382. That left the dollar index, which measures the U.S. currency against six other units, 0.6% higher at 99.29. Sterling was 0.5% lower at $1.338, while the New Zealand dollar sank 1.1% to $0.5895. Carol Kong, currency strategist at Commonwealth Bank of Australia, said the markets are in wait-and-see mode on how Iran responds, with more worries about the positive inflationary impact of the conflict than the negative economic impact. "The currency markets will be at the mercy of comments and actions from the Iranian, Israeli and U.S. governments," Kong said. "The risks are clearly skewed to further upside in the safe haven currencies if the parties escalate the conflict." The dollar was up 1.1% against the yen at 147.73 after touching a one-month high earlier in the session. The U.S. currency cast a shadow on other Asian currencies, including the rupiah, ringgit and the Philippine peso. Bank of America strategists said the dollar-yen can reprice higher if oil prices remain elevated, noting Japan imports almost all of its petroleum, more than 90% of which comes from the Middle East, while the U.S. is largely energy-independent. "We think USD/JPY works as a hedge against an escalation in geopolitical tension in the Middle East with positive carry," they said in a note. Iran vowed to defend itself a day after the U.S. dropped 30,000-pound bunker-buster bombs onto the mountain above Iran's Fordow nuclear site. American leaders urged Tehran to stand down while pockets of anti-war protests emerged in U.S. cities. In a step towards what is widely seen as Iran's most effective threat to hurt the West, its parliament approved a move to close the Strait of Hormuz. Nearly a quarter of global oil shipments pass through the narrow waters that Iran shares with Oman and the United Arab Emirates. "Markets appear to be treating the U.S. strikes on Iran as a contained event for now, rather than the start of a broader war," said Charu Chanana, chief investment strategist at Saxo. "The muted haven flows suggest investors are still assuming this is a one-off escalation, not a disruption to global oil supply or trade." While the dollar has reprised its role as a safe haven due to the rapid spike in geopolitical risks, the relatively muted moves suggest investors remain wary of going all in on the greenback. The U.S. currency has dropped 8.5% this year against its major rivals as economic uncertainty from President Donald Trump's tariffs and concern over their impact on U.S. growth led investors to scurry for alternatives.
Newsweek
2 hours ago
- Newsweek
Project 2025 Coauthor: Trump Tariffs Could Endanger Health Care
Advocates for ideas and draws conclusions based on the interpretation of facts and data. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump is right to play hardball on trade with Europe. The European Union targets leading American companies with rules, fines, and other punitive actions that undermine their ability to do business in EU countries and deliver technologies to their citizens and small businesses. However, there are some lines that we should not cross in response to trade tensions—like the tariffs President Trump is expected to impose on imported medicines any day now. The president can levy so-called Section 232 tariffs on imports deemed a threat to national security. While that rationale may apply to medicines from China, imports from Europe and Japan pose no such threat. Tariffs on European and Japanese medicines would harm Americans who rely on prescription drugs. They would disrupt the small firms that underpin our health care system—disproportionately hurting early-stage biotech startups, specialized manufacturers, and independent pharmacies, especially in rural communities. These companies operate lean and are laser-focused. Most emerging biotechs, in fact, revolve around a single drug candidate. They have small teams, tight budgets, and years of regulatory hurdles ahead. Many rely on active pharmaceutical ingredients sourced from Europe to develop their therapies. Tariffs on those imports wouldn't just slow medical progress—they could stop it in its tracks. That's because small firms aren't on the sidelines of drug development. They are the front line. In 2024, nearly two-thirds of all U.S. clinical trials were launched by emerging biopharma companies. Last year, small businesses developed 85 percent of newly approved drugs and brought more than half to market on their own. Breakthroughs require reliable, affordable inputs. A full one-third of the active pharmaceutical ingredients in Americans' medicines come from Europe. Building new U.S. pharmaceutical plants can take up to a decade and cost $2 billion. Waiting that long isn't an option for a startup betting everything on one product. Even established manufacturers aren't immune. Many of America's nearly 1,600 domestic facilities—which produce approximately one-half of U.S. medicines—still depend on European ingredients. Tariffs would spike their costs and strain an already fragile supply chain. Some may be forced to pull workers off the factory floor. WASHINGTON, DC - APRIL 02: U.S. President Donald Trump holds up a chart while speaking during a 'Make America Wealthy Again' trade announcement event in the Rose Garden at the White House on April 2,... WASHINGTON, DC - APRIL 02: U.S. President Donald Trump holds up a chart while speaking during a 'Make America Wealthy Again' trade announcement event in the Rose Garden at the White House on April 2, 2025 in Washington, DC. MoreThen there are the pharmacies. Unlike big chains, independent pharmacies often can't negotiate bulk deals or absorb sudden price hikes. A steep tariff could erase already thin margins, forcing many to shut their doors, including in underserved and rural communities that already lack sufficient access to pharmacies. In 2023 alone, the U.S. imported close to $130 billion in pharmaceutical products from Europe. A tariff, of 25 percent for instance, could translate to tens of billions in new costs for our health care system. Those dollars won't just hit corporate balance sheets. They'll show up in Medicare and Medicaid budgets, insurance premiums, and out-of-pocket costs for seniors and working families. Placing tariffs on medicines is not like taxing handbags or hubcaps. There's often no clear "substitute" for the medicine that works best for a particular patient. If a treatment is made in Ireland or Switzerland, a tariff doesn't create a U.S. version. It creates delay, financial strain, or worse—outright loss of access. Developed countries have long treated medicines as off-limits in trade disputes for one simple reason: patients' lives should never be used as leverage in a trade war. If President Trump's goal is to keep America from relying on adversaries like China for key medicines, life-saving European drugs shouldn't be caught in the crossfire. Entrepreneurs and small business owners are not asking for special favors. They merely want predictability, light government intervention, access to markets, and a fair shot. Drug tariffs will inject turmoil into a sector that needs stability. For biotech startups and other small businesses, these tariffs aren't just a cost increase—they are an existential threat. President Trump is right to confront trade inequities, intellectual property theft, and other countries' lack of compliance with previous trade deals. But when it comes to medicines, tariffs will cause broad-based harm. Practically speaking, tariffs will not build domestic capacity any time soon and they will not protect American innovation. Medicines must remain exempt from tariff actions against allies like Europe and Japan. American patients and the small businesses powering our health care system need this stability and assurance. Karen Kerrigan is president and CEO of the Small Business and Entrepreneurship Council ( in Washington, D.C. She was the author of Project 2025's chapter on the Small Business Administration. The views expressed in this article are the writer's own.
Newsweek
3 hours ago
- Newsweek
How Iran Could Close the Strait of Hormuz
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Iranian lawmakers have said blocking the strategic Strait of Hormuz could be one retaliatory response to U.S. and Israeli attacks, and have given symbolic approval to the decision. U.S. Secretary of State Marco Rubio urged China on Sunday to press Iran against closing the Strait following U.S. strikes on Iranian nuclear sites. Why It Matters If the Iranian government blocks passage through the Strait, Asian markets are expected to be most hit, but American markets will be too, with energy prices likely to rise. Oil prices jumped on Monday to their highest since January following the U.S. strikes. Located between the Persian Gulf and the Gulf of Oman, connecting to the wider Indian Ocean, the chokepoint on one of the world's busiest maritime routes is vital to global energy security and it handles roughly 20 percent of global oil trade. In this photo released by the Iran's Revolutionary Guard on Tuesday, Jan. 17, 2023, a missile is launched from a boat during a naval drill in the Persian Gulf, Iran. In this photo released by the Iran's Revolutionary Guard on Tuesday, Jan. 17, 2023, a missile is launched from a boat during a naval drill in the Persian Gulf, Iran. Iranian Revolutionary Guard/AP What To Know Since 2019, Iran has repeatedly used the Strait of Hormuz to apply pressure. In June 2019, it was accused of attacking two oil tankers with limpet mines. It also seized the British-flagged Stena Impero in retaliation for Britain detaining an Iranian tanker near Gibraltar. In 2023, units of Iran's Islamic Revolutionary Guard Corps briefly seized oil tankers in Gulf waters, prompting U.S. naval deployments. That demonstrated Iran's ability to target shipping. The strait is little over 20 miles wide at its narrowest point and while it could not be closed in the traditional sense, Iran could make it too dangerous for ships to pass — so that shipping companies and their insurers would stop According to one lawmaker, Seyyed Ali Yazdi Khah, speaking before the U.S. strikes, Iran would be compelled to shut down the Strait to "protect its national interest," in the face of "global arrogance" from the U.S. and the West, Mehr News Agency reported earlier this week. The U.S. Energy Information Administration (EIA) said an average of 20 million barrels per day—around one fifth of global petroleum liquids consumption—moved through the waterway in 2024 and that volume has remained stable through the first quarter of 2025. Iran's Options H.I. Sutton, an independent and open-source intelligence analyst, outlined several scenarios for disruption on his YouTube channel. One feasible option is mining the strait. Bottom sea mines are placed on the seabed and designed to detonate when a ship passes nearby. Iran could also employ anti-ship ballistic missiles—a method used by its allied Yemeni Houthis since 2023 to disrupt Red Sea traffic. The IRGC has drone carriers, fast attack boats, and Ghadir-class submarines—small, short-range vessels capable of launching torpedoes and laying mines. Sutton noted that despite limited lethal power, Iran's numerous platforms and long-range strike ability pose a serious deterrent. Iran has been conducting large-scale naval drills in the region, including with Chinese and Russian naval vessels, signaling broader strategic coordination and an additional challenge for the U.S. and Western allies. But Iran would need to operate carefully in the Strait to avoid disrupting Chinese oil shipments, a lifeline for its economy and a cornerstone of its strategic partnership with Beijing. What People Are Saying U.S. Secretary of State Marco Rubio to Fox Business Sunday Morning Futures: "Well, I would encourage the Chinese Government in Beijing to call them about that, because they heavily depend on the Straits of Hormuz for their oil. If they do that, it'll be another terrible mistake. It's economic suicide for them if they do it. And we retain options to deal with that. But other countries should be looking at that as well. It would hurt other countries' economies a lot worse than ours. It would be, I think, a massive escalation that would merit a response not just by us but from others." Marko Papic, chief strategist at BCA Research, told Newsweek: "Oil prices would likely double, to well above $100. The extent to which that price shock would be sustainable is unclear." U.S. Energy Information Administration (EIA) in a report last week: "Saudi Arabia and the UAE have some infrastructure in place that can bypass the Strait of Hormuz, which may somewhat mitigate any transit disruptions through the strait." What Happens Next Iran has signaled that there will be a response to U.S. strikes, but has not said exactly what yet and whether that would include targeting shipping in the Strait or Hormuz.
